BALAJIPHOS vs TRANSPEK: Stock Comparison
TRANSPEK is the larger company by market capitalisation. BALAJIPHOS shows a higher ROE and a higher ROCE, while TRANSPEK shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BALAJIPHOS leads 2; TRANSPEK leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | BALAJIPHOS | TRANSPEK |
|---|---|---|
| Live Price | — | ₹1,232.6 |
| Day Change | — | -2.36% |
| Volume | — | 5,657 |
| 52-Week High | — | ₹1,447.9 |
| 52-Week Low | — | ₹952.3 |
| Distance from 52W High | — | -14.87% |
Valuation
| Metric | BALAJIPHOS | TRANSPEK |
|---|---|---|
| Market Cap | ₹278 Cr | ₹760 Cr |
| P/E Ratio | 23.26x | 15.66x |
| P/B Ratio | 2.7x | 0.8x |
| EPS | ₹3.97 | ₹15.98 |
| Book Value | ₹38.13 | ₹1,373.97 |
| Dividend Yield | 0% | 1.47% |
Growth
| Metric | BALAJIPHOS | TRANSPEK |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | -20.53% | 0% |
| Qtr Profit Growth | -7.7% | 0% |
Profitability & Leverage
| Metric | BALAJIPHOS | TRANSPEK |
|---|---|---|
| ROE | 11.28% | 5.95% |
| ROCE | 9.54% | 6.87% |
| Net Margin | 0% | 7.35% |
| Operating Margin | 10.89% | 11.15% |
| Debt to Equity | 0.47x | 0.06x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | BALAJIPHOS | TRANSPEK |
|---|---|---|
| Promoter Holding | 69.9% | 57.27% |
| FII Holding | 3.54% | 0.02% |
| DII Holding | 0.11%▼ 0.66 pp | 1.05%▼ 0.55 pp |
| Public Holding | 26.45%▲ 0.66 pp | 41.66%▲ 0.75 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BALAJIPHOS and TRANSPEK.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.